Appeals court deals FTC another pay-for-delay defeat

Thursday, 26 April 2012

Steven C Sunshine, counsel to Watson Pharmaceutical
An appeals court has again shot down a US Federal Trade Commission (FTC) lawsuit attempting to brand pay-for-delay pharmaceutical settlement deals anti-competitive – casting more doubt on the chances of its long-running bid to end the deals succeeding in the courtroom.

Drug makers argue against FTC AndroGel challenge

Premium Article - Friday, 12 November 2010

FTC pay-for-delay suit in focus
Several pharmaceutical companies have told a US appeals court that the Federal Trade Commission’s (FTC) attempt to overturn a failed pay-for-delay prosecution should be thrown out.

Back to top

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK
Queen's Award logo International Bar Association logo American Bar Association strategic partner logo

Copyright © 2012 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 207 908 1188 / Fax: +44 207 229 6910

http://www.globalcompetitionreview.com | editorial@globalcompetitionreview.com